中慧生物-B(02627.HK)申请H股全流通

Group 1 - The company Zhonghui Biotech-B (02627.HK) announced that it has submitted an application to the China Securities Regulatory Commission for the conversion of 81,661,895 unlisted shares into H-shares [1] - The conversion aims for the listing of these shares on the Hong Kong Stock Exchange, facilitating full circulation of H-shares [1] - The expected date for this conversion and listing is October 15, 2025 [1]